Lumibird SA
PAR:LBIRD

Watchlist Manager
Lumibird SA Logo
Lumibird SA
PAR:LBIRD
Watchlist
Price: 7.3 EUR Market Closed
Market Cap: 160.6m EUR
Have any thoughts about
Lumibird SA?
Write Note

Lumibird SA
Total Liabilities & Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Lumibird SA
Total Liabilities & Equity Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Liabilities & Equity CAGR 3Y CAGR 5Y CAGR 10Y
Lumibird SA
PAR:LBIRD
Total Liabilities & Equity
€405.2m
CAGR 3-Years
10%
CAGR 5-Years
22%
CAGR 10-Years
23%
Ses Imagotag SA
PAR:SESL
Total Liabilities & Equity
€1B
CAGR 3-Years
36%
CAGR 5-Years
29%
CAGR 10-Years
24%
Groupe SFPI SA
PAR:SFPI
Total Liabilities & Equity
€607.1m
CAGR 3-Years
4%
CAGR 5-Years
2%
CAGR 10-Years
51%
Gea Grenobloise Electronique Automatisme SA
PAR:GEA
Total Liabilities & Equity
€92.2m
CAGR 3-Years
-1%
CAGR 5-Years
-3%
CAGR 10-Years
0%
I2S SA
PAR:ALI2S
Total Liabilities & Equity
€20.3m
CAGR 3-Years
9%
CAGR 5-Years
13%
CAGR 10-Years
8%
Vusiongroup SA
PAR:VU
Total Liabilities & Equity
€1.1B
CAGR 3-Years
32%
CAGR 5-Years
27%
CAGR 10-Years
25%
No Stocks Found

Lumibird SA
Glance View

Market Cap
163.7m EUR
Industry
Electrical Equipment

Lumibird SA engages in the design, manufacturing and marketing of lasers. The company is headquartered in Lannion, Bretagne and currently employs 914 full-time employees. The firm offers a range of products, including compact pulsed Nd, double-pulse Nd, tunable laser systems, flash-lamp pumped lasers, diode-pumped solid-state lasers, semiconductor laser modules and intense pulsed light instruments, among others. Lumibird provides lasers to industrial and scientific clients, as well as the medical sector, among others. The firm operates worldwide through the subsidiaries, such as Quantel Medical, which specializes in the development and marketing of diagnostic ocular ultrasound systems and surgical lasers; Quantel USA, which designs and produces fiber lasers, glass laser systems and tunable lasers, and Quantel Derma AT, which focuses on the development, production and sales of the laser technology products in the areas of dermatology and aesthetics.

LBIRD Intrinsic Value
17.05 EUR
Undervaluation 57%
Intrinsic Value
Price

See Also

What is Lumibird SA's Total Liabilities & Equity?
Total Liabilities & Equity
405.2m EUR

Based on the financial report for Dec 31, 2023, Lumibird SA's Total Liabilities & Equity amounts to 405.2m EUR.

What is Lumibird SA's Total Liabilities & Equity growth rate?
Total Liabilities & Equity CAGR 10Y
23%

Over the last year, the Total Liabilities & Equity growth was 9%. The average annual Total Liabilities & Equity growth rates for Lumibird SA have been 10% over the past three years , 22% over the past five years , and 23% over the past ten years .

Back to Top